Association between adherence to evidence-based guidelines for the prescription of non-steroidal anti-inflammatory drugs and the incidence of gastric mucosal lesions in Japanese patients

Journal of Gastroenterology

Volumn 45, Issue 9, 2010, Pages 944-951

  Tsumura, Hidetaka ^a   Fujita, Tsuyoshi ^a   Tamura, Isamu ^a   Morita, Yoshinori ^a   Yoshida, Masaru ^a   Toyonaga, Takashi ^a   Mukai, Hidekazu ^b   Inokuchi, Hideto ^c   Kutsumi, Hiromu ^a   Azuma, Takeshi ^a  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b YODOGAWA CHRISTIAN HOSPITAL   (Japan)

^c HYOGO CANCER CENTER   (Japan)

Author keywords

Adherence; Gastric mucosal lesions; NSAIDs guideline

Indexed keywords

ANTICOAGULANT AGENT; CORTICOSTEROID; DICLOFENAC; HISTAMINE H2 RECEPTOR ANTAGONIST; LOXOPROFEN; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTAGLANDIN DERIVATIVE; PROTON PUMP INHIBITOR; SULINDAC;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BONE DISEASE; BONE TUMOR; CANCER PAIN; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG MEGADOSE; DRUG SAFETY; DRUG UTILIZATION; EVIDENCE BASED MEDICINE; FEMALE; GASTROINTESTINAL ENDOSCOPY; HEADACHE; HIGH RISK PATIENT; HUMAN; INCIDENCE; INTERVERTEBRAL DISK HERNIA; JAPANESE; LOW BACK PAIN; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; OSTEOARTHRITIS; OSTEOPOROSIS; PAIN; PATIENT ATTITUDE; PATIENT COMPLIANCE; PERIPHERAL OCCLUSIVE ARTERY DISEASE; POSTOPERATIVE PAIN; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; STOMACH MUCOSA LESION;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DRUG INTERACTIONS; ENDOSCOPY, GASTROINTESTINAL; EVIDENCE-BASED MEDICINE; FEMALE; GASTRIC MUCOSA; GUIDELINE ADHERENCE; HUMANS; MALE; MIDDLE AGED; PEPTIC ULCER; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES AS TOPIC; PREVALENCE; RETROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 77956926826     PISSN: 09441174     EISSN: 14355922     Source Type: Journal    
DOI: 10.1007/s00535-010-0236-2     Document Type: Article

References (37)

1. Francois Clinard Marc Bardou Catherine Sgro Nathalie Lefevre Francis Raphael Francois Paille, et al. 2001 Non-steroidal anti-inflammatory and cytoprotective drug co-prescription in general practice Eur J Clin Pharmacol 57 737 743 1:CAS:528:DC%2BD3MXovVWgs70%3D 10.1007/s00228-001-0378-5 11829204 (Pubitemid 34031267)
2. AS Taha N Hudson CJ Hawkey AJ Swannell PN Trye J Cottrell, et al. 1996 Famotidine for the prevention of gastric and duodenal ulcers caused by nonsteroidal anti-inflammatory drugs N Engl J Med 334 1435 1439 1:CAS:528:DyaK28XktF2kurk%3D 10.1056/NEJM199605303342204 8618582 (Pubitemid 26157439)
3. J Weil MJ Langman P Wainwright DH Lawson M Rawlins RF Logan, et al. 2000 Peptic ulcer bleeding: accessory risk factors and interactions with non-steroidal anti-inflammatory drugs Gut 46 27 31 1:STN:280: DC%2BD3c%2FmvFCqtw%3D%3D 10.1136/gut.46.1.27 10601050 (Pubitemid 30307672)
4. Y Shiokawa T Nobenaga T Saitoh S Asaji A Ogawa 1991 Epidemiological study on upper digestive injuries by non-steroidal anti-inflammatory drugs J Jpn Rheum Assoc 31 96 111 1:STN:280:DyaK3MzhtlClsA%3D%3D (in Japanese)
5. SE Gabriel L Jaakkinmainen C Bombardier 1991 Risk for serious gastrointestinal complications related to use of nonsteroidal anti-inflammatory drugs: a meta-analysis Ann Intern Med 115 787 796 1:STN:280: DyaK38%2Fislagtw%3D%3D 1834002
6. SV Bellary PE Isaacs FI Lee 1991 Upper gastrointestinal lesions in elderly patients presenting for endoscopy; relevance of NSAID usage Am J Gastroenterol 86 961 964 1:STN:280:DyaK3MzhsVGltQ%3D%3D 1858761
7. JF Fries CA Williams DA Bloch DA Michel 1991 Nonsteroidal anti-inflammatory drug-associated gastropathy: incidence and risk factor models Am J Med 91 213 222 1:STN:280:DyaK3MzmvVyjsA%3D%3D 10.1016/0002-9343(91)90118-H 1892140
8. FL Lanza FK Chan EM Quigley 2009 Guidelines for prevention of NSAID-related ulcer complications Am J Gastroenterol 104 728 738 10.1038/ajg.2009.115 19240698
9. Recommendation for the medical management of osteoarthritis of the hip and knee. 2000 update. American College of Rheumatology Subcommittee on Osteoarthritis Guidelines. Arthritis Rheum 2000;43:1905-15.
10. FL Lanza 1998 A guideline for the treatment and prevention of NSAID-induced ulcers: members of the ad hoc committee on practice parameters of the American college of gastroenterology Am J Gastroenterol 93 11 2037 2046 1:CAS:528:DyaK1cXnsFGns7o%3D 10.1111/j.1572-0241.1998.00588.x 9820370 (Pubitemid 29076848)
11. CH MacLean 2001 Quality indicators for the management of osteoarthritis in vulnerable elders Ann Intern Med 135 711 721 1:STN:280:DC%2BD3MnhtFantA%3D%3D 11601954
12. NS Abrahama HB El-Serag ML Johnson C Hartman P Richardson WA Ray, et al. 2005 National adherence to evidence-based guidelines for the prescription of nonsteroidal anti-inflammatory drugs Gastroenterology 129 4 1171 1178 10.1053/j.gastro.2005.08.003 (Pubitemid 41446857)
13. WE Smalley MR Griffin 1996 The risks and costs of upper gastrointestinal disease attributable to NSAIDs Gastroenterol Clin North Am 25 2 373 396 1:STN:280:DyaK2s%2FhtlCgtg%3D%3D 10.1016/S0889-8553(05)70253-3 9229579 (Pubitemid 26161475)
14. S Hernandez-Diaz LA Rodriguez 2000 Association between nonsteroidal anti-inflammatory drugs and upper gastrointestinal tract bleeding/perforation Arch Intern Med 160 2093 2099 1:STN:280:DC%2BD3czptVKgtQ%3D%3D 10.1001/archinte.160.14.2093 10904451
15. HJ Moens JJ Van Croonenborg MJ Al PM van den Bemt J Lourens ME Numans Working Group, Kwaliteitsinstituut voor de Gezondheidszorg CBO 2003 Guideline: 'NSAID use and the prevention of gastric damage' Ned Tijdschr Geneeskd 148 604 608
16. MM Wofe DR Lichtenstein G Singh 1999 Gastrointestinal toxicity of nonsteroidal anti-inflammatory drugs N Eng J Med 340 1888 1899 10.1056/NEJM199906173402407 (Pubitemid 29272670)
17. EM van Soest MC Sturkenboom JP Dieleman KM Verhamme PD Siersema EJ Kuipers 2007 Adherence to gastroprotection and the risk of NSAID-related upper gastrointestinal ulcers and haemorrhage Aliment Pharmacol Ther 26 2 265 275 10.1111/j.1365-2036.2007.03358.x 17593072 (Pubitemid 46985490)
18. FL Lanza D Fakouhi A Rubin RE Davis MF Rack C Nissen, et al. 1989 A double-blind placebo-controlled comparison of the efficacy and safety of 50, 100, and 200 micrograms of misoprostol q.i.d. in the prevention of ibuprofen-induced gastric and duodenal mucosal lesions and symptoms Am J Gastroenterol 84 633 636 1:CAS:528:DyaL1MXkslSmtrc%3D 2499187
19. LE Targownik CJ Metge S Leung DG Chateau 2008 The relative efficacies of gastroprotective strategies in chronic users of nonsteroidal anti-inflammatory drugs Gastroenterology 134 937 944 1:CAS:528:DC%2BD1cXls1Gmurw%3D 10.1053/j.gastro.2008.01.010 18294634 (Pubitemid 351451965)
20. FL Lanza 1986 A double-blind study of prophylactic effect of misoprostol on lesions of gastric and duodenal mucosa induced by oral administration of tolmetin in healthy subjects Dig Dis Sci 31 131 136 10.1007/BF01309338
21. C Hawkey NJ Talley ND Yeomans R Jones JJ Sung G Langstrom, et al. 2005 Improvements with esomeprazole in patients with upper gastrointestinal symptoms taking non-steroidal anti-inflammatory drugs, including selective COX-2 inhibitors Am J Gastroenterol 100 1028 1036 1:CAS:528:DC%2BD2MXkvVSms7g%3D 10.1111/j.1572-0241.2005.41465.x 15842575 (Pubitemid 40769038)
22. L Hooper TJ Brown R Elliott K Payne C Roberts D Symmons 2004 The effectiveness of five strategies for the prevention of gastrointestinal toxicity induced by non-steroidal anti-inflammatory drugs: systematic review BMJ 329 948 1:CAS:528:DC%2BD2cXhtVKnsLfJ 10.1136/bmj.38232.680567.EB 15475342 (Pubitemid 39422910)
23. Rostom A, Dube C, Wells G, Tugwell P, Welch V, Jolicoeur E, et al. Prevention of NSAID-induced gastroduodenal ulcers. Cochrane Database Syst Rev. 2002;(4):CD002296.
24. JM Scheiman ND Yeomans NJ Talley N Vakil FK Chan Z Tulassay, et al. 2006 Prevention of ulcers by esomeprazole in at-risk patients using non-selective NSAIDs and COX-2 inhibitors Am J Gastroenterol 101 4 701 710 1:CAS:528:DC%2BD28Xktlylsbw%3D 10.1111/j.1572-0241.2006.00499.x 16494585
25. H Tsumura I Tamura H Tanaka R Chinzei T Ishida A Masuda, et al. 2007 Prescription of non steroidal anti-inflammatory drugs and co-prescribed drugs for mucosal protection: analysis of the present status based on questionnaires obtained from orthopedists in Japan Intern Med 46 927 931 10.2169/ internalmedicine.46.0003 17603228 (Pubitemid 47261633)
26. EBM ni motozuku ikaiyou shinnryou gaidolain dai2han. NSAID kaiyou yobou. in EBM ni motozuku ikaiyou shinnryou gaidolain. Jihou, 2007 (in Japanese).
27. TJ Schnitzer American College of Rheumatology 2002 Update of ACR guidelines for osteoarthritis: role of the coxibs J Pain Symptom Manage 23 Suppl 4 S24 S30 10.1016/S0885-3924(02)00372-X 11992747 (Pubitemid 34476936)
28. R Sorensen ML Hansen SZ Abildstrom A Hvelplund C Torp-Pedersen GH Gislason 2009 Risk of bleeding in patients with acute myocardial infarction treated with different combinations of aspirin, clopidogrel, and vitamin K antagonists in Demark: a retrospective analysis of nationwide registry data Lancet 374 1967 1974 1:CAS:528:DC%2BD1MXhsFGgtL3F 10.1016/S0140-6736(09)61751-7 20006130
29. Y Naito T Yoshikawa S Iinuma N Yagi K Matsuyama Y Boku, et al. 1998 Rebamipide protects against indomethacin-induced gastric mucosal injury in healthy volunteers in a double-blind, placebo-controlled study Dig Dis Sci 43 83 89
30. FL Lanza GL Royer RS Nelson TT Chen CE Sechman MF Rack 1981 A comparative endoscopic evaluation of the damaging effects of nonsteroidal anti-inflammatory agents on the gastric and duodenal mucosa Am J Gatroenterol 75 17 21 1:STN:280:DyaL3M3gsVentg%3D%3D
31. K Kobayashi Y Mizushima A Yanagawa R Kasukawa J Ito T Koshino, et al. 1990 Prophylactic effects ranitidine, a H2 receptor antagonist, on gastric and duodenal lesions induced by nonsteroidal anti-inflammatory agents J Adult Dis 20 253 264 (in Japanese)
32. MG Robinson JW Griffin J Bowers FJ Kogan DG Kogut FL Lanza, et al. 1989 Effect on ranitidine on gastroduodenal mucosal damage induced by nonsteroidal anti-inflammatory drugs Dig Dis Sci 34 424 428 1:STN:280:DyaL1M7lt1OitQ%3D%3D 10.1007/BF01536266 2646087 (Pubitemid 19088785)
33. ND Yeomans J Naesdal 2008 Systematic review: ulcer definition in NSAID ulcer prevention trials Aliment Pharmacol Ther 27 465 472 1:STN:280: DC%2BD1c7ktFKmuw%3D%3D 10.1111/j.1365-2036.2008.03610.x 18194499 (Pubitemid 351300861)
34. D-C Suh E Hunsche H-C Shin P Mavros 2008 Co-prescribing of proton pump inhibitors among chronic users of NSAIDs in the UK Rheumatology 47 458 463 10.1093/rheumatology/kem375 18263598
35. T Arakawa Y Fujiwara JD Sollano Q Ahu U Kachintorn AA Rani, et al. 2009 IGIS study group: a questionnaire-based survey on the prescription of non-steroidal anti-inflammatory drugs by physicians in East Asian countries in 2007 Digestion 79 177 185 10.1159/000211713 19342858
36. JQ Huang S Sridhar RH Hunt 2002 Role of Helicobacter pylori infection and non-steroidal anti-inflammatory drugs in peptic-ulcer disease: a meta-analysis Lancet 359 14 22 1:CAS:528:DC%2BD38XmsV2msQ%3D%3D 10.1016/S0140-6736(02)07273-2 11809181 (Pubitemid 34119190)
37. GA Coté JP Rice W Bulsiewicz JP Norvell K Christensen A Bobb, et al. 2008 Use of physician education and computer alert to improve targeted use of gastroprotection among NSAID users Am J Gastroenterol 103 1097 1103 10.1111/j.1572-0241.2008.01907.x 18477341 (Pubitemid 351678001)